Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Health Catalyst (HCAT) Enterprise Value (2019 - 2026)

Health Catalyst filings provide 9 years of Enterprise Value readings, the most recent being -$108.8 million for Q1 2026.

  • On a quarterly basis, Enterprise Value rose 68.18% to -$108.8 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$108.8 million, a 68.18% increase, with the full-year FY2025 number at -$95.7 million, up 75.58% from a year prior.
  • Enterprise Value hit -$108.8 million in Q1 2026 for Health Catalyst, down from -$95.7 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$91.5 million in Q3 2025 to a low of -$425.4 million in Q1 2022.
  • Median Enterprise Value over the past 5 years was -$343.8 million (2023), compared with a mean of -$299.4 million.
  • Biggest five-year swings in Enterprise Value: tumbled 59.67% in 2022 and later soared 76.36% in 2025.
  • Health Catalyst's Enterprise Value stood at -$363.5 million in 2022, then increased by 12.59% to -$317.7 million in 2023, then fell by 23.38% to -$392.0 million in 2024, then skyrocketed by 75.58% to -$95.7 million in 2025, then fell by 13.67% to -$108.8 million in 2026.
  • The last three reported values for Enterprise Value were -$108.8 million (Q1 2026), -$95.7 million (Q4 2025), and -$91.5 million (Q3 2025) per Business Quant data.